Author:
Tokic Visnja,Barisic Ingeborg,Huzjak Nevenka,Petkovic Giorgie,Fumic Ksenija,Paschke Eduard
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology, and Child Health
Reference13 articles.
1. Brooks DA, Kakavanos R, Hopwood JJ (2003) Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder. Trends Mol Med 9:450–453
2. Grewal SS, Wynn R, Abdenur JE, Burton BK, Gharib M, Haase C, Hayashi RJ, Shenoy S, Sillence D, Tiller GE, Dudek ME, van Royen-Kerkhof A, Wraith JE, Woodard P, Young GA, Wulffraat N, Whitley CB, Peters C (2005) Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome. Genet Med 7:143–146
3. Guffon N, Wraith J, Braakman T (2004) Aldurazyme (laronidase) enzyme replacement therapy in MPS I: preliminary safety and pharmacodynamic data in children less than 5 years of age. Annual Meeting of Society for Inherited Metabolic Disorders, Orlando, Florida, 7-10 March 2004
4. Kachur E, Del Maestro R (2000) Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 47:223–228
5. Kakavanos R, Turner C, Hopwood J, Kakkis E, Brooks D (2003) Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I. Lancet 361:1608–1613
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献